| Literature DB >> 34198984 |
Bailey Engle1, Molly Masters2, Jane Ann Boles2, Jennifer Thomson2.
Abstract
Fat deposition is important to carcass value and some palatability characteristics. Carcasses with higher USDA quality grades produce more value for producers and processors in the US system and are more likely to have greater eating satisfaction. Using genomics to identify genes impacting marbling deposition provides insight into muscle biochemistry that may lead to ways to better predict fat deposition, especially marbling and thus quality grade. Hereford steers (16) were managed the same from birth through harvest after 270 days on feed. Samples were obtained for tenderness and transcriptome profiling. As expected, steaks from Choice carcasses had a lower shear force value than steaks from Select carcasses; however, steaks from Standard carcasses were not different from steaks from Choice carcasses. A significant number of differentially expressed (DE) genes was observed in the longissimus lumborum between Choice and Standard carcass RNA pools (1257 genes, p < 0.05), but not many DE genes were observed between Choice and Select RNA pools. Exploratory analysis of global muscle tissue transcriptome from Standard and Choice carcasses provided insight into muscle biochemistry, specifically the upregulation of extracellular matrix development and focal adhesion pathways and the downregulation of RNA processing and metabolism in Choice versus Standard. Additional research is needed to explore the function and timing of gene expression changes.Entities:
Keywords: beef cattle; gene expression; quality grade
Year: 2021 PMID: 34198984 PMCID: PMC8300355 DOI: 10.3390/ani11071910
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 2.752
Main effect of quality grade on average shear force and carcass characteristics of red-faced Hereford steers.
| Grade | Shear Force | HCW | Fat | REA | KPH | Yield Grade (±SD) | Marbling 1 |
|---|---|---|---|---|---|---|---|
| Standard | 66.3 b ± 12.4 | 250.6 b ± 33.0 | 0.43 b ± 0.21 | 57.68 c ± 5.27 | 1.60 c ± 0.22 | 2.46 ab ± 0.4 | 266 c ± 16.7 |
| Select | 84.3 a ± 13.9 | 282.9 a ± 23.0 | 0.64 a ± 0.21 | 67.23 b ± 2.72 | 1.80 b ± 2.27 | 2.62 a ± 0.37 | 330 b ± 18.7 |
| Choice | 71.3 b ± 13.0 | 283.2 a ± 15.9 | 0.58 a ± 0.23 | 72.13 a ± 4.87 | 2.08 a ± 0.38 | 2.35 b ± 0.24 | 463 a ± 15.0 |
| <0.0001 | <0.0001 | 0.0104 | <0.0001 | <0.0001 | 0.0077 | <0.0001 |
1 200 = Traces, 300 = Slight, 400 = Small, 500 = Modest. a, b, c means within the column with different superscripts are significantly different p ≤ 0.05.
Main effect of aging on the shear force of steaks from red-faced Hereford steers.
| Age | Shear Force |
|---|---|
| 1 | 89.9 a ± 16.5 |
| 3 | 80.7 b ± 17.8 |
| 7 | 71.0 b ± 13.7 |
| 14 | 65.3 b ± 11.9 |
| 21 | 62.9 c ±9.7 |
a, b, c Means within the column with different superscripts are significantly different p ≤ 0.05.
Upregulated differentially expressed genes with high fold changes in Choice compared to Standard LD muscle.
| Gene ID | Gene Name | Fold Change | Corrected | Function |
|---|---|---|---|---|
| TET1 | Tet methylcytosine dioxygenase 1 | 12.37 | 0.031 | DNA and iron binding |
| ETV5 | ETS variant 5 | 9.89 | 0.045 | Regulation of transcription, neuromuscular transmission |
| BRB | Brain ribonuclease | 9.89 | 0.002 | Nucleic acid binding, endonuclease activity, hydrolase activity |
| DKK3 | Dickkopf WNT signaling pathway inhibitor 3 | 9.89 | 0.002 | Multicellular organism development, negative regulation of WNT signaling |
| BASE2 | Beta-secretase 2 | 9.28 | 0.003 | Proteolysis, protein catabolic processes |
| TNFAIP2 | TNF-alpha-induced protein 2 | 8.67 | 0.008 | SNARE binding, exocytosis |
| HPGD | 5-hydroxyprostaglandin dehydrogenase | 6.80 | 0.016 | Growth factor receptor signaling |
| PCGF6 | Polycomb group ring finger 6 | 6.18 | 0.025 | Negative regulation of transcription |
| SERPINE1 | Serpin family E member 1 | 4.93 | 0.006 | Angiogenesis, protease binding, enzyme inhibitor activity |
| ANKRD2 | Ankyrin repeat domain 2 | 2.06 | 0.016 | Protein/titin binding, skeletal muscle development/differentiation |
Downregulated differentially expressed genes with high fold changes in Choice compared to Standard LD muscle.
| Gene ID | Gene Name | Fold Change | Corrected | Function |
|---|---|---|---|---|
| RFC2 | Replication factor C subunit | 11.77 | 0.0008 | DNA binding, DNA replication, Cell cycle activity |
| PQLC2 | PQ loop repeat containing 2 | 9.01 | 0.0003 | Amino acid transmembrane transport |
| PPM1F | Protein phosphatase, Mg2+/Mn2+ dependent 1F | 8.09 | 0.0008 | Protein dephosphorylation, positive regulation of transcription, negative regulation of protein kinase |
| TBPL1 | TATA-box binding protein-like 1 | 4.56 | 0.027 | DNA binding, positive regulation of transcription |
| GLB1 | Galactosidase beta 1 | 4.31 | 0.028 | Carbohydrate metabolic process, hydrolase activity |
| INSIG2 | Insulin-induced gene | 3.9 | 0.027 | Lipid metabolic process |
| GALNT11 | Polypeptide N-acetylgalactosaminyltransferase 11 | 3.74 | 0.027 | Notch binding, protein glycosylation, transferase activity |
| TAF7-201 | TATA-box binding protein associated factor 7 | 3.07 | 0.0004 | Negative regulation of transcription, thyroid hormone signaling |
| NKTR | Natural killer cell triggering receptor | 2.75 | 0.0005 | Protein folding and protein refolding |
| PSMA4 | Proteasome subunit alpha 4 | 2.17 | 0.0008 | Proteolysis, protein catabolic processes |
Upregulated differentially expressed genes with high fold changes in Choice compared to Select LD muscle.
| Gene ID | Gene Name | Fold Change | Corrected | Function |
|---|---|---|---|---|
| MX1 | MX1 MX dynamin-like GTPase 1 | 11.25 | <0.000 | Extracellular signaling, immune response, recognition of pregnancy |
| CHRND | Cholinergic receptor nicotinic delta subunit | 7.59 | 0.002 | Muscle acetylcholine receptor |
| UBA7 | Brain ribonuclease | 7.24 | <0.000 | Cytokine signaling |
| RSAD2 | Radical S-adenosyl methionine domain-containing 2 | 6.9 | <0.001 | Iron and sulfur binding, catalytic activity, protein self-association |
| OAS1Z | 2′,5′-oligoadenylate synthetase 1 | 6.12 | <0.001 | Cytokine signaling, neutrophil gene expression |
| NUDT8 | Nudix hydrolase 8 | 5.55 | 0.004 | Coenzyme A diphosphatase |
| NMRAL1 | NmrA-like redox sensor 1 | 5.52 | <0.001 | Protein binding, nuclear signaling |
| CELSR1 | Cadherin EGF LAG seven-pass G-type receptor 1 | 5.42 | 0.005 | Positive regulation of cell migration and angiogenesis |
| SQLE | Squalene epoxidase | 5.23 | 0.01 | Modulator of plasma membrane lipid profile, cholesterol synthesis inhibition |
| BOLA-DOB | Major histocompatibility complex, class II, DO beta | 5.2 | 0.044 | Immune function, self-recognition, |
Downregulated differentially expressed genes with high fold changes in Choice compared to Select LD muscle.
| Gene ID | Gene Name | Fold Change | Corrected | Function |
|---|---|---|---|---|
| PLA2G7 | Phospholipase A2 group VII | 7.00 | Anti-inflammatory activity, lipoprotein metabolism | |
| BACH2 | BTB domain and CNC homolog 2 | 6.52 | 0.01 | Innate immune response, PAX5 signaling |
| ALK | ALK receptor tyrosine kinase | 6.28 | 0.027 | Cellular signaling |
| ZNF184 | Zinc finger protein 184 | 6.02 | 0.001 | Cellular signaling |
| ZP2 | Zona pellucida glycoprotein 2 | 5.71 | 0.01 | Reproduction, Ca2+ transport |
| SMOX | Spermine oxidase | 5.67 | 0.02 | ROS mediation, catabolism of polyamines |
| PRDM15 | PR/SET domain 15 | 5.05 | 0.05 | Neurogenesis, epigenetic modifier |
| TNFRSF12A | TNF receptor superfamily member 12A | 4.86 | 0.006 | Cytokine signaling |
| CD8A | CD8a molecule | 4.61 | 0.016 | T-cell activity, immune function |
| DNAJB14 | DNAJ heat-shock protein family (Hsp40) member B14 | 4.53 | 0.001 | Endoplasmic reticulum function, protein catabolism |
Gene set enrichment analysis of KEGG Pathways, and Gene Ontology of DE genes upregulated in Choice compared to Standard LD muscle.
| KEGG Pathways | ||
|---|---|---|
| Pathway Name | Count | |
| TNF signaling pathway | 15 | <0.001 |
| Signaling pathway regulating pluripotency of stem cells | 16 | 0.004 |
| Thyroid hormone signaling pathway | 14 | 0.004 |
| Neurotrophin signaling pathway | 14 | 0.009 |
| Apoptosis | 8 | 0.01 |
| Insulin resistance | 12 | 0.02 |
| Type 2 diabetes mellitus | 7 | 0.03 |
| FoxO signaling pathway | 13 | 0.03 |
| Focal adhesion | 17 | 0.05 |
| Gene Ontology | ||
| Cellular Compartment | ||
| Proteinaceous extracellular matrix | 27 | <0.001 |
| Cortical actin cytoskeleton | 8 | 0.01 |
| Biological process | ||
| Canonical Wnt signaling pathway | 13 | <0.01 |
| Negative regulation of catalytic activity | 7 | 0.03 |
| Regulation of cell migration | 17 | 0.05 |
| Molecular Function | ||
| Endopeptidase activity | 7 | 0.03 |
| Metal ion binding | 90 | 0.06 |
Gene set enrichment analysis of KEGG Pathways and Gene Ontology of DE genes downregulated in Choice compared to Standard LD muscle.
| KEGG Pathways | ||
|---|---|---|
| Pathway Name | Count | |
| RNA transport | 24 | <0.001 |
| RNA Degradation | 25 | <0.001 |
| Spliceosome | 19 | 0.002 |
| cGMP-PKG signaling pathway | 20 | 0.007 |
| NF-kappa B signaling pathway | 13 | 0.01 |
| Lysosome | 16 | 0.02 |
| Basal transcription factors | 8 | 0.02 |
| Metabolic pathways | 98 | 0.02 |
| Vascular smooth muscle contraction | 14 | 0.04 |
| Gene Ontology | ||
| Cellular Compartment | ||
| Cytoplasm | 288 | <0.001 |
| Small-subunit processome | 8 | 0.009 |
| Biological Process | ||
| RNA methylation | 4 | 0.002 |
| Positive regulation of interferon-beta production | 7 | 0.003 |
| DNA repair | 19 | 0.003 |
| mRNA splicing | 16 | 0.003 |
| Negative regulation of MAP kinase activity | 8 | 0.004 |
| Molecular Function | ||
| Metal ion binding | 137 | <0.001 |
| Nucleic acid binding | 58 | <0.001 |
| RNA methyltransferase activity | 5 | <0.001 |